about
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsA molecular epidemiological investigation of Ascaris on Unguja, Zanzibar using isoenyzme analysis, DNA barcoding and microsatellite DNA profiling.Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposurePhase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.The Antibacterial Activity of Acetic Acid against Biofilm-Producing Pathogens of Relevance to Burns Patients.Protocol for a systematic review of quantitative burn wound microbiology in the management of burns patientsChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infectionAntibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature BiofilmsProtective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: an in vitro study.A systematic review of quantitative burn wound microbiology in the management of burns patients.Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infection.The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: a systematic review.Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease.Antimicrobial peptide coatings for hydroxyapatite: electrostatic and covalent attachment of antimicrobial peptides to surfaces.In vitro activity of an engineered honey, medical-grade honeys, and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates.Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens.Universal extraction method for gastrointestinal pathogens.An evaluation of the Mast D69C AmpC Detection Disc Set for the detection of inducible and derepressed AmpC -lactamasesThe potential of visible blue light (405 nm) as a novel decontamination strategy for carbapenemase-producing enterobacteriaceae (CPE)Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients
P50
Q28731894-54A88FF5-5044-4BD6-B8A1-0BD9D95E8BEDQ33909667-A36062B4-BCEB-433C-B5D4-E81A84A474DAQ33974904-1A3D07AC-1560-4A71-89C3-1B5616ABD08BQ34257253-5831942D-C367-4EFB-8A2D-0B1590DA8CD1Q35623459-28D8B52A-A549-40AF-ACE3-70854005DE36Q35741984-D063503E-9BC3-4613-9DC7-913ABDA62DAEQ35767635-3AFF3703-D792-41D7-BCC5-BA59DC1C059CQ36255473-80F60163-F4A2-47ED-B8EA-06BFC6E49672Q36460499-82C4115C-9819-41BC-B668-90AE97832919Q36871970-2181FDBF-E75A-4626-97CF-DCF6A9D0CAC0Q36903515-732443FC-38CC-4E76-835B-B091E6835AB9Q37002434-94F907A4-80D9-4BB7-8BE5-EA1B6ABA3B69Q37403767-B9FA0123-C0C3-4D35-A912-199BE1A5DB1BQ37641378-92E50F23-1F04-4715-9361-B3EC69547C11Q38630881-7D32A41A-9C2A-42F9-A77D-1CDAA1EAD915Q38636429-752AAE6F-892C-44AB-90EE-E8AB6D83E444Q39141393-B44CF7E9-73E3-4DAB-8D10-5E0FC9DD2B2FQ39417659-B3B89F6E-6FDF-45A6-8411-4D2474B589D5Q39507421-28231100-B04E-489B-BF6A-6092BB106133Q40375650-AF61A30D-B5E2-496A-8071-E76AA1D8BB3AQ40791138-1C693AAE-824C-423F-96B5-F8CECD006DD5Q41101388-B63638FA-960C-445A-B543-3A82CA4889A3Q42256100-5CC8E58D-AE19-4B83-981D-BF52B188F38FQ57077397-C6E9AF71-A088-4F75-A13B-B5961F87DD50Q61446708-2C3DE885-9552-4364-BD81-ECBAD119BDCFQ90129034-0069D7DA-FA7C-4B75-9FED-6F402054D757
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fenella D Halstead
@ast
Fenella D Halstead
@en
Fenella D Halstead
@es
Fenella D Halstead
@nl
Fenella D Halstead
@sl
type
label
Fenella D Halstead
@ast
Fenella D Halstead
@en
Fenella D Halstead
@es
Fenella D Halstead
@nl
Fenella D Halstead
@sl
prefLabel
Fenella D Halstead
@ast
Fenella D Halstead
@en
Fenella D Halstead
@es
Fenella D Halstead
@nl
Fenella D Halstead
@sl
P106
P21
P31
P496
0000-0002-2833-2926